NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Topoisomerase


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Data on enzyme research described by researchers at Vanderbilt University
2009 NOV 9 ... "Human topoisomerase II alpha utilizes a two-metal-ion mechanism for DNA cleavage. One of the metal ions ...
Subject: Enzyme Research
Price: $3.00
*
Data on phytotherapy published by researchers at Federal University
2009 NOV 17 ... "Naphthoquinones have been studied extensively due to their activity as topoisomerase inhibitors. These enzymes are critical to DNA replication in cells," scientists in ...
Subject: Phytotherapy
Price: $3.00
*
Findings from University of Alabama, Department of Chemistry advance knowledge in enzyme research
2009 NOV 9 ... Research findings, 'Quinoline alkaloids as intercalative topoisomerase inhibitors,' are discussed in a new report. According to recent research from the ...
Subject: Enzyme Research
Price: $3.00
*
Findings from University of Louisiana in natural products reported
2009 NOV 17 ... of 1 (2-5 and 7-13) were synthesized based on docking studies and tested for their topoisomerase I and II alpha inhibitory activity," scientists in the United States report. ...
Subject: Natural Products
Price: $3.00
*
Mahidol University, Medical Department reports research in trichomoniasis
2009 NOV 16 ... a common sexually transmitted protozoan parasite, is increasing worldwide, and DNA topoisomerase II may provide a new target for anti-trichomonal drug development. In this study, T. ...
Subject: Trichomoniasis
Price: $3.00
*
Mersana Therapeutics Publishes Review Article Detailing Advantages of its Lead Cancer Compound in Journal of Advanced Drug Delivery Reviews
2009 NOV 23 ... M.D., both of Mersana, and provided an overview of XMT-1001 in the context of other topoisomerase I inhibitors conjugated to polymers or encapsulated in liposomes. XMT-1001 ...
Subject: Cancer
Price: $3.00
*
New DNA research study results from Shanghai Institute of Materia Medica, Research Division described
2009 NOV 23 ... to possess anticancer activities and to induce G(2)-M arrest through inhibiting topoisomerase II accompanied by Chk1 degradation. The current study was designed to precisely dissect ...
Subject: DNA Research
Price: $3.00
*
New findings from A.Y. Grahn and co-authors in the area of glioma published
2009 NOV 23 ... convectable non-PEGylated liposomal formulation that can be used to encapsulate both the topoisomerase I inhibitor topotecan (topoCED ™) and paramagnetic gadodiamide (gadoCED ™), ...
Subject: Glioma
Price: $3.00
*
New findings from Uppsala University in the area of solid cancer described
2009 NOV 1 ... as haematological malignancies. Cryptolepine activity showed highest correlations to topoisomerase II and microtubule targeting drugs. In the cell lines cryptolepine activity was ...
Subject: Solid Cancer
Price: $3.00
*
New salmonellosis research reported from M. Gunell and co-authors
2009 NOV 16 ... the emergence of a highly mobile qnr genotype that, in the absence of mutation within topoisomerase genes, confers the nontypical quinolone resistance phenotype in S. enterica isolates. ...
Subject: Salmonellosis
Price: $3.00
*
Reports from Aarhus University highlight recent research in life sciences
2009 NOV 24 ... nick at a single genomic site in Saccharomyces cerevisiae and thus mimics a stabilized topoisomerase I-DNA cleavage complex. We took advantage of a mutant Flp recombinase that can introduce ...
Subject: Life Sciences
Price: $3.00
*
Reports on cancer findings from Technical University of Munich provide new insights
2009 NOV 1 ... "We show that HDAC2, but not HDAC1, confers resistance towards the topoisomerase II inhibitor etoposide in PDAC cells. Correspondingly, the class I selective HDACi ...
Subject: Cancer
Price: $3.00
*
Reports outline pneumonia study findings from University of London
2009 NOV 16 ... "Quinazoline-2,4-diones, such as PD 0305970, are new DNA gyrase and topoisomerase IV (topo IV) inhibitors with potent activity against gram-positive pathogens, including ...
Subject: Pneumonia
Price: $3.00
*
Research from University of Sussex provides new data about DNA research
2009 NOV 1 ... of DNA, which, if it occurs near sites of endogenous DNA damage or in the presence of topoisomerase poisons, can result in abortive topoisomerase-induced ...
Subject: DNA Research
Price: $3.00
*
Research from University of Texas provide new insights into cirrhosis
2009 NOV 23 ... of AMA or sp100 status, there was an association of anticentromere B (CENP-B) and anti-topoisomerase antibodies (ATA) with higher alkaline phosphatase levels (p = 0.051 and p = 0.003, ...
Subject: Cirrhosis
Price: $3.00
*
Scientists at National Taiwan University release new data on hepatocellular cancer
2009 NOV 16 ... apoptosis induced by camptothecin or etoposide. Tunicamycin neither modified the topoisomerase levels nor inhibited the ATM activation caused by camptothecin and etoposide. The data ...
Subject: Hepatocellular Cancer
Price: $3.00
*
Studies from China Pharmaceutical University provide new data on tissue engineering
2009 NOV 9 ... to recent research from Nanjing, People's Republic of China, "A novel series of topoisomerase I (Top I) inhibitors were designed on the basis of camptothecin using scaffold ...
Subject: Tissue Engineering
Price: $3.00
*
Studies from University of Washington in the area of DNA research described
2009 NOV 23 ... According to recent research from the United States, "Human topoisomerase I binds DNA in a topology-dependent fashion with a strong preference for supercoiled ...
Subject: DNA Research
Price: $3.00
*
Study findings from Medical University of Bialystok broaden understanding of drug development
2009 NOV 1 ... 4[bis(2-chloroethyl)amino]benzenebutanoic acid. The new compounds were evaluated as DNA topoisomerase II inhibitors," wrote K. Bielawski and colleagues, Medical University of Bialystok. ...
Subject: Drug Development
Price: $3.00
*
Study results from M.L. Martinezrobles and colleagues in the area of DNA research published
2009 NOV 16 ... plasmids arising as a result of DNA replication in Escherichia coli cells whose topoisomerase IV activity was inhibited," scientists writing in the journal Nucleic Acids Research ...
Subject: DNA Research
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login